Asensus Surgical, Inc. stock is up 31.43% since 30 days ago. The next earnings date is Feb 29, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 48.48% of the previous 32 November’s closed higher than October. 50% of analysts rate it a buy.
Asensus Surgical, Inc. engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. The company's products include Senhance Surgical system, a multi-port robotic surgery system that allows up to four arms to control robotic instruments.